← All companiesPProtagonist Therapeutics, Inc
PTGX - CIK 0001377121
Protagonist Therapeutics, Inc net income by year
Protagonist Therapeutics, Inc (PTGX) reported net income of -$130.15M for fiscal year 2025, as filed in its audited annual report with the SEC.
PTGX annual net income
PTGX net income 2014-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | -$130.15M | -147.3% |
| FY 2024 | $275.19M | +448.5% |
| FY 2023 | -$78.96M | +38.0% |
| FY 2022 | -$127.39M | -1.5% |
| FY 2021 | -$125.55M | -89.8% |
| FY 2020 | -$66.15M | +14.3% |
| FY 2019 | -$77.19M | -98.3% |
| FY 2018 | -$38.92M | -5.3% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does Protagonist Therapeutics, Inc make?
Protagonist Therapeutics, Inc (PTGX) reported net income of -$130.15M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Protagonist Therapeutics, Inc's net income changed over time?
Between fiscal 2014 and fiscal 2025, Protagonist Therapeutics, Inc's net income declined from -$11.07M to -$130.15M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.